ITT INC.

ITT NYSE CIK: 0000216228

Company Information

Industry Pumps & Pumping Equipment
SIC Code 3561
Entity Type operating
SEC Category Large accelerated filer
Business Address 100 WASHINGTON BLVD, STAMFORD, CT, 06902
Mailing Address 100 WASHINGTON BLVD, STAMFORD, CT, 06902
Phone 914.641.2000
Fiscal Year End 1231
EIN 811197930

Financial Overview

FY2025 FY

$3.94B
Revenue
$4.08B
Stockholders' Equity
$1.74B
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
4/A Insider transaction amendment March 11, 2026 View on SEC
4/A Insider transaction amendment March 11, 2026 View on SEC
4 Insider stock transaction report March 6, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC

Annual Reports

10-K February 9, 2026
  • ITT INC. delivered strong 2023 financial performance with 7.5% revenue growth to $3.2 billion and 12% net income growth.
  • The company provided robust 2024 guidance, projecting 4-7% revenue growth and adjusted EPS between $4.40 and $4.60.
View Analysis

Material Events

8-K Acquisition December 5, 2025
High Impact
  • ITT INC. is acquiring SPX FLOW, Inc. for $4.775 billion, paid mostly with cash ($4.075 billion) and 3.84 million shares of ITT common stock.
  • This acquisition is a strategic move to expand ITT's offerings and market presence in industrial, health, and nutrition sectors.
View Analysis

Insider Trading

STRONG SELL 1 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3561)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.